SGLT2 inhibitors decrease glucose reabsorption, increase heart rate, decrease blood pressure, and decrease body weight. Created Date: 1/1/1601 12:00:00 AM ...
While the SGLT2 inhibitors are approved as monotherapy, they are mainly used in combination with metformin and/or other agents; ...
SGLT2 inhibitors. Increase urinary excretion of glucose. Canagliflozin. Dapagliflozin. Empagliflozin. Invokana. Farxiga. Jardiance. Sulfonylureas. Increase insulin ...
Nuevas generaciones de Antidiabéticos Potenciadores del efecto incretina Inhibidores de SGLT2 Mª Teresa Llanos García Farmacéutica Atención Primaria Área V
The Role of the Kidney and SGLT2 Inhibitors in Type 2 Diabetes Pamela M. Katz, MD, Lawrence A. Leiter, MD, FRCPC Canadian Journal of Diabetes
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM) Jan N. Basile
... compound should become active in early 2015 and we will be receiving milestone payments during the development of our SGLT2 Inhibitor.
INCRETINAS e INHIBIDORES DPP-4EN DIABETES MELLITUS TIPO 2. Dr. Marco De León Espitia. Médico Internista – Intensivista. H.U.S. – U.I.S. Departamento de
Author: Capuder, Katherine Created Date: 12/11/2015 10:53:38 Title: Emerging CV Safety Data With SGLT2 Inhibitors Last modified by: Capuder, Katherine
Sodium-glucose-cotransporter-2 (SGLT2) inhibitors. ... Management of type 2 diabetes: new and future developments in treatment. The Lancet, Vol 378. July 9 2011, 182-195.
Objectives. Pharmacists will be able to: Describe SGLT2 inhibitors. Compare available SGLT-2 inhibitors. Identifyideal candidates for SGLT2 inhibitors
PPThunter.com is a PPT search engine and does not upload or store any files on its server.
Powered by: PPThunter.com - Free PowerPoint Search Engine